CoChat

Interleukin-6 and C-reactive protein as predictors of cognitive decline in late midlife

Open access
Singh-Manoux, Archana, Dugravot, Aline, Brunner, Eric, Kumari, Meena, Shipley, Martin, Elbaz, Alexis, Kivimaki, Mika · 2014 · Neurology

The DOI matches its Crossref record; 42 of the 44 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: Peripheral inflammatory markers are elevated in patients with dementia. In order to assess their etiologic role, we examined whether interleukin-6 (IL-6) and C-reactive protein (CRP) measured in midlife predict concurrently assessed cognition and subsequent cognitive decline. METHODS: Mean value of IL-6 and CRP, assessed on 5,217 persons (27.9% women) in 1991-1993 and 1997-1999 in the Whitehall II longitudinal cohort study, were categorized into tertiles to examine 10-year decline (assessments in 1997-1999, 2002-2004, and 2007-2009) in standardized scores (mean = 0, SD = 1) of memory, reasoning, and verbal fluency using mixed models. Mini-Mental State Examination (MMSE) was administered in 2002-2004 and 2007-2009; decline ≥3 points was modeled with logistic regression. Analyses were adjusted for baseline age, sex, education, and ethnicity; further analyses were also adjusted for smoking, obesity, Framingham cardiovascular risk score, and chronic diseases (cancer, coronary heart disease, stroke, diabetes, and depression). RESULTS: In cross-sectional analysis, reasoning was 0.08 SD (95% confidence interval [CI] -0.14, -0.03) lower in participants with high compared to low IL-6. In longitudinal analysis, 10-year decline in reasoning was greater (ptrend = 0.01) among participants with high IL-6 (-0.35; 95% CI -0.37, -0.33) than those with low IL-6 (-0.29; 95% CI -0.31, -0.27). In addition, participants with high IL-6 had 1.81 times greater odds ratio of decline in MMSE (95% CI 1.20, 2.71). CRP was not associated with decline in any test. CONCLUSIONS: Elevated IL-6 but not CRP in midlife predicts cognitive decline; the combined cross-sectional and longitudinal effects over the 10-year observation period corresponded to an age effect of 3.9 years.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1212/wnl.0000000000000665

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 42 references

Research works printed but not linked: 2

  1. Heim AW. AH 4 Group Test of General Intelligence. Windsor, UK: NFER-Nelson Publishing Company Ltd.; 1970.
  2. 10.1002/ana.10265 · DOI · Paper page

Cited by

See all 262

Metadata

Authors
Singh-Manoux, A., Dugravot, A., Brunner, E., Kumari, M., Shipley, M., Elbaz, A., & Kivimaki, M.
Affiliations
  • From INSERM (A.S.-M., A.D., A.E.), U1018, Centre for Research in Epidemiology and Population Health, Hôpital Paul Brousse, Villejuif Cedex, France; Department of Epidemiology and Public Health (A.S.-M., E.B., M. Kumari, M.S., A.E., M. Kivimaki), University College London, UK; Centre de Gérontologie (A.S.-M.), Hôpital Ste Périne, AP-HP; and University Versailles St-Quentin en Yvelines (A.D.), France.
  • Inserm (FR)
Venue
Neurology
Published
2014-08-05
Volume
83
Issue
6
Pages
486-493
ISSN
  • 0028-3878 (ISSN-L)
  • 1526-632X
OpenAlex
W2166002623
Cited by
237
References
44
Citations by year
2026: 20 · 2025: 28 · 2024: 18 · 2023: 27 · 2022: 14 · 2021: 25 · 2020: 16 · 2019: 26 · 2018: 22 · 2017: 11 · 2016: 16 · 2015: 10 · 2014: 4
FWCI
10.43
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Neurology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Open Access at Essex (University of Essex) (acceptedVersion)
  • HAL (submittedVersion, other-oa)
  • UCL Discovery (University College London) (submittedVersion)
Funders
  • British Heart Foundation (R01 AG013196, R01AG034454, K013351, RG/13/2/30098, R01HL036310)
  • National Institutes of Health
  • Medical Research Council (MR/K013351/1, K013351, R01AG034454)
  • Economic and Social Research Council (ES/K005146/1, R01AG034454, ES/J023299/1, ES/H029745/1, R01HL036310)
  • National Institute on Aging (R01AG034454, R01AG013196)
  • National Heart, Lung, and Blood Institute (R01HL036310)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
Keywords
interleukin-6, C-reactive protein, cognitive decline, midlife, dementia, inflammation, reasoning, memory, verbal fluency, Mini-Mental State Examination, Whitehall II cohort, biomarkers
MeSH terms
Adult, C-Reactive Protein, Cognition Disorders, Cross-Sectional Studies, Female, Humans, Longitudinal Studies, Male, Middle Aged, Predictive Value of Tests, Cohort Studies, Biomarkers, Interleukin-6

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Interleukin-6 and C-reactive protein as predictors of cognitive decline in late midlife. https://app.cochat.ai/papers/10.1212/wnl.0000000000000665
The paper
Singh-Manoux, A., Dugravot, A., Brunner, E., Kumari, M., Shipley, M., Elbaz, A., & Kivimaki, M. (2014). Interleukin-6 and C-reactive protein as predictors of cognitive decline in late midlife. Neurology. https://doi.org/10.1212/wnl.0000000000000665

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.